Establishment of Human Lung Stem Cell Proliferation System and Organoid Construction in COPD - Trial NCT06275230
Access comprehensive clinical trial information for NCT06275230 through Pure Global AI's free database. This phase not specified trial is sponsored by China-Japan Friendship Hospital and is currently Not yet recruiting. The study focuses on Chronic Obstructive Pulmonary Disease. Target enrollment is 30 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
China-Japan Friendship Hospital
Timeline & Enrollment
N/A
Mar 20, 2024
Dec 31, 2025
Primary Outcome
Number of Patients completed bronchoscope.
Summary
The goal of this study is to proliferate human lung stem cell in vitro in order to establish
 a lung organoid derived from patients with COPD. The main question it aims to answer are:
 
 - Can human lung stem cell proliferate in vitro.
 
 - Can a lung organoid derived from patients with COPD be established. Participants will be
 sampled during pulmonary bronchoscope for organoid establishment.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06275230
Non-Device Trial